London/Moscow, 20 July 2007 – LAWFUEL – The Law Firm Newswire – Baker & McKenzie has advised HealthTech Corporation Limited on its sale of 100% of its Aquavision soft drinks manufacturer bottling facility in Russia to the Coca-Cola Hellenic Bottling Company for €191.5 million. The sale is subject to regulatory clearances.
Aquavision is a newly constructed production facility near Moscow, the largest consumer market in Russia. The facility covers 35 hectares and has four production lines, warehousing facilities and office space.
HealthTech Corporation Limited is one of the largest corporations in Eurasia in the biotechnologies, health and healthy lifestyle markets.
James Richards, corporate Partner at Baker & McKenzie, said: ”We were very pleased to act for our client, HTC, on the sale of this strategic bottling facility to Coca-Cola. It is another example of the strength of our M&A practice in Russia, as well as our expertise in English law M&A transactions in Russia.”
Vahagn Manukyan, Managing Director of HTC, said: ”We are grateful to Baker & McKenzie, in signing the deal with Coca-Cola. We were impressed by their outstanding professionalism, and by the exceptional enthusiasm and energy displayed by the M&A teams in London and in Moscow.”
The Baker & McKenzie team in London was led by Partner James Richards, and associates David Allen and Simon Cleobury. Baker & McKenzie in Moscow was led by Partners Paul Melling and Alexey Trusov and associate Dmitry Fedotov.
Coca Cola Hellenic Bottling Company was advised by Orrick in Moscow.